CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI ...
GE HealthCare has obtained US Food and Drug Administration (FDA) clearance for a trio of new products within its Signa MRI portfolio, as the company looks to consolidate its dominant market position ...
GE HealthCare GEHC recently unveiled its next-generation SIGNA MRI portfolio, the 3T SIGNA Bolt and 1.5T SIGNA Sprint with Freelium, aimed at boosting efficiency, advancing precision diagnostics and ...
SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in ...
SIGNA Bolt1, a new 3T MRI scanner, is designed with a next-gen gradient system engineered to support precision diagnostics, clinical efficiency, and advanced research capability. SIGNA Sprint with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results